Form D · Other Health Care
Bond Biosciences, Inc.
Parkville, MO · CIK 0001824224
Offering snapshot reported Oct 5, 2026 · SEC filing
- Reported sold
- $7.61M Offering amount: $15M
- Investors reported
- 122 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 1, 2026 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$5,927,939 → $7,614,879
- Reported investors83 → 122
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 5, 2026 | Amendment | $7,614,879 | $1,686,940vs Jun 4, 2026 | 122 | SEC filing |
| Jun 4, 2026 | Amendment | $5,927,939 | $585,059vs Apr 8, 2026 | 83 | SEC filing |
| Apr 8, 2026 | Initial | $5,342,880 | No comparison | 64 | SEC filing |
| Jan 29, 2026 | Amendment | $4,500,000 | No comparison | 91 | SEC filing |
| Dec 8, 2025 | Amendment | $4,065,000 | $250,000vs Oct 22, 2025 | 84 | SEC filing |
| Oct 22, 2025 | Amendment | $3,815,000 | $275,000vs Sep 24, 2024 | 83 | SEC filing |
| Sep 24, 2024 | Amendment | $3,540,000 | $910,000vs Sep 6, 2024 | 71 | SEC filing |
| Sep 6, 2024 | Initial | $2,630,000 | No comparison | 51 | SEC filing |
| Jan 3, 2022 | Initial | $6,810,666 | No comparison | 81 | SEC filing |
| Dec 8, 2020 | Amendment | $4,999,991 | $1,934,582vs Nov 4, 2020 | 57 | SEC filing |
| Nov 4, 2020 | Initial | $3,065,409 | No comparison | 19 | SEC filing |
| Sep 14, 2020 | Initial | $200,000 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $529K
- Finders' fees
- $0
- Form D file number
- 021-579597
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Collage Venture Partners, LLC | 316063 | Stonehaven, LLC · CRD 118913 |
Source: Form D, filed Oct 5, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Beckloff | Director |
| Cory Berkland | Director, Executive |
| Timothy Opler | Director |
| Michael A. Riley | Director, Executive |
| Jay Shepard | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
170 English Landing Drive Suite 201 B
Parkville, MO, 64152
Parkville, MO, 64152